🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Treatment Acquiring Traction Via Social Media

Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged fat-burning effects. Followers are urged to contact these profiles privately for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a flourishing market exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers promote the substance there before redirecting buyers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, doctors and chemists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals injecting substances of uncertain source.

Some experts said the demand for the experimental drug could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and customer regulations, potentially leading to penalties, legal action or prison.

Platform Reaction and Content Elimination

According to the social media company, the platform has taken down problematic content and banned related hashtags and query recommendations. The company stated it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Investigations also discovered communities with up to nine thousand members marketing retatrutide using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, populated with photos of slimming results, positive testimonials and detailed guides for preparing or administering at home.

After minutes of joining one group, a seller posted WhatsApp details, where most purchases occur. The seller sent an guidebook and guaranteed shipping within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage.

Item Details and Costs

Inside these communities, posts display dark colored packages with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with purified liquid, or pre-filled pens usually priced at £160 for 20mg. When questioned how much time a pen should last, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service stated it regularly moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they cannot confirm. Even if the research behind this drug is valid, these digital versions may not include what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has already encountered individuals harmed by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to potentially serious health risks”.